When success hinges on the ability of your CDMO to produce robust and scalable processes, you need to be sure your partner has the experience required. BioStem's extensive process development and manufacturing capabilities help our partners realize effective products at a viable cost while translating to reliable cGMP manufacturing.
BioStem's capabilities cover the entire product development continuum for perinatal tissue and cell-based programs, including discovery, process/analytical development, scale-up, and cGMP manufacturing services. Our knowledge and experience in the science and development of this field is an excellent point of pride for our organization. Our dedicated customer focus and situational agility, combined with a solid scientific base, position us as the ideal partner for our clients' process development needs.
BioStem Life Sciences Capabilities
Capabilities of BioStem Life Sciences include:
Cell Line Development and Characterization
- Flow Cytometry
- Cell-based Assays
- Adherent and Suspension Cultures
- - Mammalian, Insect, and Stem Cells
Storage of Cell Banks
- Cell Bank Retrieval and Shipment
Perinatal Tissue Contract Manufacturing Platforms
- Contract R&D
- Process Development and GMP readiness
- - Amniotic Fluid
- - Placental Membranes
- - Umbilical Cord Blood
- - Umbilical Cord Tissue
- Program Management
- - Tissue Procurement
- - Analytical Outsourcing
- - Medical Release
- CMC submissions
Are you interested in working with us?
If you have questions about the company, our lab, our scientific team or anything else, please feel free to contact us.